389 related articles for article (PubMed ID: 11180501)
21. Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.
McPhie AA; Barr GA
Dev Psychobiol; 2009 Nov; 51(7):544-52. PubMed ID: 19708041
[TBL] [Abstract][Full Text] [Related]
22. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
23. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
24. Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats.
Pavlovic ZW; Bodnar RJ
Brain Res; 1998 Jan; 779(1-2):158-69. PubMed ID: 9473650
[TBL] [Abstract][Full Text] [Related]
25. Mechanical allodynia and thermal hyperalgesia upon acute opioid withdrawal in the neonatal rat.
Sweitzer SM; Allen CP; Zissen MH; Kendig JJ
Pain; 2004 Jul; 110(1-2):269-80. PubMed ID: 15275777
[TBL] [Abstract][Full Text] [Related]
26. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
27. Local opiate withdrawal in locus coeruleus neurons in vitro.
Ivanov A; Aston-Jones G
J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
[TBL] [Abstract][Full Text] [Related]
28. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
Wei E; Sigel SS; Loh HH; Way EL
J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
[TBL] [Abstract][Full Text] [Related]
29. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
30. Discriminative stimulus effects of naltrexone in the morphine-dependent rat.
Gellert VF; Holtzman SG
J Pharmacol Exp Ther; 1979 Dec; 211(3):596-605. PubMed ID: 574545
[TBL] [Abstract][Full Text] [Related]
31. Lesions of the periaqueductal gray disrupt input to the rostral ventromedial medulla following microinjections of morphine into the medial or basolateral nuclei of the amygdala.
McGaraughty S; Farr DA; Heinricher MM
Brain Res; 2004 May; 1009(1-2):223-7. PubMed ID: 15120601
[TBL] [Abstract][Full Text] [Related]
32. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
[TBL] [Abstract][Full Text] [Related]
33. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
34. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
[TBL] [Abstract][Full Text] [Related]
35. Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey.
Chieng B; Christie MJ
Neuropharmacology; 2009 Sep; 57(4):430-7. PubMed ID: 19580818
[TBL] [Abstract][Full Text] [Related]
36. GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal.
Bagley EE; Gerke MB; Vaughan CW; Hack SP; Christie MJ
Neuron; 2005 Feb; 45(3):433-45. PubMed ID: 15694329
[TBL] [Abstract][Full Text] [Related]
37. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
38. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
39. Naloxone alters the local metabolic rate for glucose in discrete brain regions associated with opiate withdrawal.
Kraus MA; Piper JM; Kornetsky C
Brain Res; 1996 Jun; 724(1):33-40. PubMed ID: 8816253
[TBL] [Abstract][Full Text] [Related]
40. Sensitization to morphine withdrawal in guinea-pigs.
Mizutani A; Arvidsson J; Chahl LA
Eur J Pharmacol; 2005 Feb; 509(2-3):135-43. PubMed ID: 15733548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
